|1.||WO||WO/2014/118685 - METHOD OF ALTERING THE ACIDIC VARIANT CONTENT OF ANTIBODY||07.08.2014||
||PCT/IB2014/058553||DR. REDDY'S LABORATORIES LIMITED||KULKARNI, Samir, R.|
The present invention is related to a method of altering the amount of acidic variants in an antibody composition. In particular, the invention employs a cation exchange chromatography with varying amounts of wash buffer column volume to alter the acidic variant content of the antibody.
|2.||WO||WO/2014/083512 - PROCESS FOR PREPARATION OF ABIRATERONE ACETATE||05.06.2014||
|PCT/IB2013/060441||DR. REDDY'S LABORATORIES LIMITED||DAHANUKAR, Vilas Hareshwar|
The present invention relates to process for the preparation of abiraterone acetate, its salts and intermediates thereof, crystalline forms of abiraterone acetate salts and purification of abiraterone acetate.
|3.||WO||WO/2014/076568 - PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORS||22.05.2014||
|PCT/IB2013/002909||DR. REDDY'S LABORATORIES LTD.||PADHI, Bijay, Kumar|
The present application discloses a pharmaceutical composition comprising a class of CETP inhibitors with improved oral bioavailability. The application further discloses compositions comprising a class of CETP inhibitor and at least one solubility improving material and optionally one or more wetting agents.
|4.||WO||WO/2014/072961 - POLYMORPHIC FORMS OF SUVOROXANT||15.05.2014||
|PCT/IB2013/060080||DR. REDDY'S LABORATORIES LIMITED||PEDDY, Vishweshwar|
Present invention relates to crystalline form of suvorexant, amorphous form of suvorexant, amorphous solid dispersion of suvorexant, processes for their preparation and pharmaceutical dosage form thereof.
|5.||WO||WO/2014/045263 - PROCESS FOR PREPARATION OF INTERMEDIATES OF TELAPREVIR||27.03.2014||
|PCT/IB2013/058808||DR. REDDY'S LABORATORIES LIMITED||IQBAL, Javed|
Provided are novel processes for preparation of (1S, 3aR, 6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylic acid and its derivatives; land their use in preparation of Telaprevir.
|6.||WO||WO/2014/041487 - ENZALUTAMIDE POLYMORPHIC FORMS AND ITS PREPARATION||20.03.2014||
|PCT/IB2013/058455||DR. REDDY'S LABORATORIES LIMITED||PEDDY, Vishweshwar|
The present application relates to crystalline and amorphous forms of Enzalutamide. The present application further relates to amorphous solid dispersions of Enzalutamide with pharmaceutically acceptable carriers. The present application also relates to a process for the preparation of Form R1 of Enzalutamide.
|7.||WO||WO/2013/153497 - SINGLE STEP FRACTIONATION METHOD||17.10.2013||
|PCT/IB2013/052785||DR. REDDY'S LABORATORIES LIMITED||PATRA, Ashish K|
Single step method of enriching highly sialylated variant/s of a protein by use of a strong ion exchange chromatography support and a p H gradient in absence of any salt gradient.
|8.||WO||WO/2013/150495 - PREPARATION OF TICAGRELOR||10.10.2013||
|PCT/IB2013/052733||DR. REDDY'S LABORATORIES LIMITED||DAHANUKAR, Vilas Hareshwar|
Provided are processes for preparing Ticagrelor and its intermediates that are useful in the processes. Also provided are salts of Ticagrelor, their processes and solid dispersion of Ticagrelor having Ticagrelor in amorphous form.
|9.||WO||WO/2013/144903 - PROCESSES FOR THE PREPARATION OF DABIGATRAN ETEXILATE||03.10.2013||
|PCT/IB2013/052500||DR. REDDY'S LABORATORIES LIMITED||DAHANUKAR, Vilas Hareshwar|
The present application relates to processes for preparing Dabigatran etexilate, including pharmaceutically acceptable salts or tautomers thereof.
|10.||WO||WO/2013/144857 - IMPROVED PROCESS FOR PRODUCING (S)-EQUOL||03.10.2013||
|PCT/IB2013/052428||DR. REDDY'S LABORATORIES LIMITED||DAHANUKAR, Vilas Hareshwar|
The present application relates to an improved process for the preparation of (S)- equol (1). The present application also relates to novel intermediates of formula (7), (7A), (8) and (9) and their use for the synthesis of (S)-equol.